Wilding IR - Search Results

1

Gastrointestinal spread of oral prolonged-release mesalazine microgranules (Pentasa) dosed as either tablets or sachet.

Wilding IR, Kenyon CJ, Hooper G. Wilding IR, et al. Aliment Pharmacol Ther. 2000 Feb;14(2):163-9. doi: 10.1046/j.1365-2036.2000.00696.x. Aliment Pharmacol Ther. 2000. PMID: 10651656 Clinical Trial.

2

Gastrointestinal transit and systemic absorption of captopril from a pulsed-release formulation.

Wilding IR, Davis SS, Bakhshaee M, Stevens HN, Sparrow RA, Brennan J. Wilding IR, et al. Pharm Res. 1992 May;9(5):654-7. doi: 10.1023/a:1015806211556. Pharm Res. 1992. PMID: 1608898 Clinical Trial.

3

Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers.

Wilding IR, Davis SS, Hardy JG, Robertson CS, John VA, Powell ML, Leal M, Lloyd P, Walker SM. Wilding IR, et al. Br J Clin Pharmacol. 1991 Nov;32(5):573-9. doi: 10.1111/j.1365-2125.1991.tb03954.x. Br J Clin Pharmacol. 1991. PMID: 1954073 Free PMC article.

4

Colonic spreading of a non-chlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitis.

Wilding IR, Kenyon CJ, Chauhan S, Hooper G, Marshall S, McCracken JS, Staab HJ, Armbrecht J. Wilding IR, et al. Aliment Pharmacol Ther. 1995 Apr;9(2):161-6. doi: 10.1111/j.1365-2036.1995.tb00365.x. Aliment Pharmacol Ther. 1995. PMID: 7605856

5

The effects of pharmaceutical excipients on small intestinal transit.

Adkin DA, Davis SS, Sparrow RA, Huckle PD, Phillips AJ, Wilding IR. Adkin DA, et al. Among authors: wilding ir. Br J Clin Pharmacol. 1995 Apr;39(4):381-7. doi: 10.1111/j.1365-2125.1995.tb04466.x. Br J Clin Pharmacol. 1995. PMID: 7640144 Free PMC article. Clinical Trial.

6

The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques.

Newman SP, Steed KP, Hardy JG, Wilding IR, Hooper G, Sparrow RA. Newman SP, et al. Among authors: wilding ir. J Pharm Pharmacol. 1994 Aug;46(8):657-60. doi: 10.1111/j.2042-7158.1994.tb03877.x. J Pharm Pharmacol. 1994. PMID: 7815279 Clinical Trial.

7

Targeting of drugs and vaccines to the gut.

Wilding IR, Davis SS, O'Hagan DT. Wilding IR, et al. Pharmacol Ther. 1994 Apr-May;62(1-2):97-124. doi: 10.1016/0163-7258(94)90006-x. Pharmacol Ther. 1994. PMID: 7991649 Review.

8

Localization of drug release sites from an oral sustained-release formulation of 5-ASA (Pentasa) in the gastrointestinal tract using gamma scintigraphy.

Hardy JG, Harvey WJ, Sparrow RA, Marshall GB, Steed KP, Macarios M, Wilding IR. Hardy JG, et al. Among authors: wilding ir. J Clin Pharmacol. 1993 Aug;33(8):712-8. doi: 10.1002/j.1552-4604.1993.tb05612.x. J Clin Pharmacol. 1993. PMID: 8408731

9

The effect of mannitol on the oral bioavailability of cimetidine.

Adkin DA, Davis SS, Sparrow RA, Huckle PD, Wilding IR. Adkin DA, et al. Among authors: wilding ir. J Pharm Sci. 1995 Dec;84(12):1405-9. doi: 10.1002/jps.2600841205. J Pharm Sci. 1995. PMID: 8748321 Clinical Trial.

10

The use of scintigraphy to provide "proof of concept" for novel polysaccharide preparations designed for colonic drug delivery.

Adkin DA, Kenyon CJ, Lerner EI, Landau I, Strauss E, Caron D, Penhasi A, Rubinstein A, Wilding IR. Adkin DA, et al. Among authors: wilding ir. Pharm Res. 1997 Jan;14(1):103-7. doi: 10.1023/a:1012019820603. Pharm Res. 1997. PMID: 9034229 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters